Surgical management of radiation-induced temporal lobe necrosis in patients with nasopharyngeal carcinoma: Report of 14 cases

Head and Neck

Volumn 33, Issue 10, 2011, Pages 1493-1500

  Mou, Yong Gao ^a,b   Sai, Ke ^a,b   Wang, Zhen Ning ^a,b   Zhang, Xiang Heng ^a,b   Lu, Yan Chun ^a,b   Wei, Da Nian ^a,b   Yang, Qun Ying ^a,b   Chen, Zhong Ping ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

diagnosis; nasopharyngeal carcinoma; neurosurgery; radiation necrosis; temporal lobe

Indexed keywords

CORTICOSTEROID; FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; BONE GRAFT; BONE NECROSIS; BRAIN NECROSIS; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; EXHAUSTION; FOLLOW UP; HUMAN; MALE; MEDICAL RECORD REVIEW; NASOPHARYNX CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION INDUCED TEMPORAL LOBE NECROSIS; RARE DISEASE; RETROSPECTIVE STUDY; SKULL BASE; SURGICAL TECHNIQUE; TEMPORAL LOBE; TRACHEOSTOMY; TRISMUS;

ADRENAL CORTEX HORMONES; ADULT; ANESTHESIA; CARCINOMA; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HEADACHE; HUMANS; INTRACRANIAL HYPERTENSION; MAGNETIC RESONANCE IMAGING; MALE; MEMORY DISORDERS; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NECROSIS; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; RADIOPHARMACEUTICALS; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; TEMPORAL LOBE; VERTIGO;

EID: 80053001561     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21639     Document Type: Article

References (48)

1. Chan AT, Teo PM, Johnson PJ,. Nasopharyngeal carcinoma. Ann Oncol 2002; 13: 1007-1015.
2. Lin S, Lu JJ, Han L, Chen Q, Pan J,. Sequential chemotherapy and intensity-modulated radiation therapy in the management of locoregionally advanced nasopharyngeal carcinoma: experience of 370 consecutive cases. BMC Cancer 2010; 10: 39 (abstract).
3. Chong VF, Fan YF, Chan LL,. Temporal lobe necrosis in nasopharyngeal carcinoma: pictorial essay. Australas Radiol 1997; 41: 392-397.
4. Shaw PJ, Bates D,. Conservative treatment of delayed cerebral radiation necrosis. J Neurol Neurosurg Psychiatry 1984; 47: 1338-1341.
5. Kohshi K, Imada H, Nomoto S, Yamaguchi R, Abe H, Yamamoto H,. Successful treatment of radiation-induced brain necrosis by hyperbaric oxygen therapy. J Neurol Sci 2003; 209: 115-117.
6. Lorenzo ND, Nolletti A, Palma L,. Late cerebral radionecrosis. Surg Neurol 1978; 10: 281-290.
7. Fee WE Jr,. Nasopharyngeal carcinoma. Curr Opin Oncol 1990; 2: 585-588.
8. Chan YL, Leung SF, King AD, Choi PH, Metreweli C,. Late radiation injury to the temporal lobes: morphologic evaluation at MR imaging. Radiology 1999; 213: 800-807.
9. Lee AW, Foo W, Chappell R, et al. Effect of time, dose, and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1998; 40: 35-42.
10. Chau RM, Teo PM, Choi PH, Cheung KY, Lee WY,. Three-dimensional dosimetric evaluation of a conventional radiotherapy technique for treatment of nasopharyngeal carcinoma. Radiother Oncol 2001; 58: 143-153.
11. Waldron J, Tin MM, Keller A, et al. Limitation of conventional two dimensional radiation therapy planning in nasopharyngeal carcinoma. Radiother Oncol 2003; 68: 153-161.
12. Zaidi H, Ay MR,. Current status and new horizons in Monte Carlo simulation of X-ray CT scanners. Med Biol Eng Comput 2007; 45: 809-817.
13. Purdy JA,. From new frontiers to new standards of practice: advances in radiotherapy planning and delivery. Front Radiat Ther Oncol 2007; 40: 18-39.
14. Chang JT, See LC, Liao CT, et al. Locally recurrent nasopharyngeal carcinoma. Radiother Oncol 2000; 54: 135-142.
15. Kam MK, Chau RM, Suen J, Choi PH, Teo PM,. Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation. Int J Radiat Oncol Biol Phys 2003; 56: 145-157.
16. Leung TW, Wong VY, Sze WK, Lui CM, Tung SY,. High-dose-rate intracavitary brachytherapy boost for early T stage nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2008; 70: 361-367.
17. Byfield JE,. Ionizing radiation and vincristine: possible neurotoxic synergism. Radiol Clin Biol 1972; 41: 129-138.
18. Price RA, Jamieson PA,. The central nervous system in childhood leukemia. II. Subacute leukoencephalopathy. Cancer 1975; 35: 306-318.
19. Lee AW, Ng WT, Hung WM, et al. Major late toxicities after conformal radiotherapy for nasopharyngeal carcinoma-patient- and treatment-related risk factors. Int J Radiat Oncol Biol Phys 2009; 73: 1121-1128.
20. Yoshii Y,. Pathological review of late cerebral radionecrosis. Brain Tumor Pathol 2008; 25: 51-58.
21. Hopewell JW, van der Kogel AJ,. Pathophysiological mechanisms leading to the development of late radiation-induced damage to the central nervous system. Front Radiat Ther Oncol 1999; 33: 265-275.
22. d'Avella D, Cicciarello R, Albiero F, et al. Quantitative study of blood-brain barrier permeability changes after experimental whole-brain radiation. Neurosurgery 1992; 30: 30-34.
23. Yuan H, Gaber MW, McColgan T, Naimark MD, Kiani MF, Merchant TE,. Radiation-induced permeability and leukocyte adhesion in the rat blood-brain barrier: modulation with anti-ICAM-1 antibodies. Brain Res 2003; 969: 59-69.
24. Norris AM, Carrington BM, Slevin NJ,. Late radiation change in the CNS: MR imaging following gadolinium enhancement. Clin Radiol 1997; 52: 356-362.
25. Tsui EY, Chan JH, Ramsey RG, et al. Late temporal lobe necrosis in patients with nasopharyngeal carcinoma: evaluation with combined multi-section diffusion weighted and perfusion weighted MR imaging. Eur J Radiol 2001; 39: 133-138.
26. Chong VF, Rumpel H, Fan YF, Mukherji SK,. Temporal lobe changes following radiation therapy: imaging and proton MR spectroscopic findings. Eur Radiol 2001; 11: 317-324.
27. Wang XL, Yin JL, Li H, Li XD, Quan JT,. PET/CT imaging of delayed radiation encephalopathy following radiotherapy for nasopharyngeal carcinoma. Chin Med J (Engl) 2007; 120: 474-478.
28. 18F-FDG PET/CT scan in following-up of nasopharyngeal carcinoma after radiotherapy. Ai Zheng 2004; 23 (Suppl 11): 1538-1541.
29. Hung GU, Tsai SC, Lin WY,. Extraordinarily high F-18 FDG uptake caused by radiation necrosis in a patient with nasopharyngeal carcinoma. Clin Nucl Med 2005; 30: 558-559.
30. Shreve PD, Anzai Y, Wahl RL,. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999; 19: 61-77.
31. Comoretto M, Balestreri L, Borsatti E, Cimitan M, Franchin G, Lise M,. Detection and restaging of residual and/or recurrent nasopharyngeal carcinoma after chemotherapy and radiation therapy: comparison of MR imaging and FDG PET/CT. Radiology 2008; 249: 203-211.
32. Tada E, Matsumoto K, Kinoshita K, Furuta T, Ohmoto T,. The protective effect of dexamethasone against radiation damage induced by interstitial irradiation in normal monkey brain. Neurosurgery 1997; 41: 209-219.
33. Lee AW, Ng SH, Ho JH, et al. Clinical diagnosis of late temporal lobe necrosis following radiation therapy for nasopharyngeal carcinoma. Cancer 1988; 61: 1535-1542.
34. Leber KA, Eder HG, Kovac H, Anegg U, Pendl G,. Treatment of cerebral radionecrosis by hyperbaric oxygen therapy. Stereotact Funct Neurosurg 1998; 70 (Suppl 1): 229-236.
35. Chuba PJ, Aronin P, Bhambhani K, et al. Hyperbaric oxygen therapy for radiation-induced brain injury in children. Cancer 1997; 80: 2005-2012.
36. Davis JC, Dunn JM, Gates GA, Heimbach RD,. Hyperbaric oxygen. A new adjunct in the management of radiation necrosis. Arch Otolaryngol 1979; 105: 58-61.
37. Gonzalez J, Kumar AJ, Conrad CA, Levin VA,. Effect of bevacizumab on radiation necrosis of the brain. Int J Radiat Oncol Biol Phys 2007; 67: 323-326.
38. Wong ET, Huberman M, Lu XQ, Mahadevan A,. Bevacizumab reverses cerebral radiation necrosis. J Clin Oncol 2008; 26: 5649-5650.
39. Torcuator R, Zuniga R, Mohan YS, et al. Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis. J Neurooncol 2009; 94: 63-68.
40. Cheng KM, Chan CM, Fu YT, et al. Brain abscess formation in radiation necrosis of the temporal lobe following radiation therapy for nasopharyngeal carcinoma. Acta Neurochir (Wien) 2000; 142: 435-441.
41. Pollock BE, Brown RD Jr,. Management of cysts arising after radiosurgery to treat intracranial arteriovenous malformations. Neurosurgery 2001; 49: 259-265.
42. Wang PC, Tu TY, Liu KD,. Cystic brain necrosis and temporal bone osteoradionecrosis after radiotherapy and surgery in a patient of ear carcinoma. J Chin Med Assoc 2004; 67: 487-491.
43. Izawa M, Chernov M, Hayashi M, et al. Management and prognosis of cysts developed on long-term follow-up after gamma knife radiosurgery for intracranial arteriovenous malformations. Surg Neurol 2007; 68: 400-406.
44. Wong ET,. Recurrent cystic radiation necrosis of the brain. Oncol Rep 1998; 5: 685-687.
45. Rajendra T, Lee KS, Leo KW, Kumar K, Chumpon C,. Previously-treated nasopharyngeal carcinoma with cystic lesions in the temporal lobe. Singapore Med J 2004; 45: 590-593.
46. Leung GK, Chan SK, Hung KN,. Triology of neurosurgical complications after radiotherapy for nasopharyngeal carcinoma. Surg Neurol 2007; 68: 466-470.
47. Hsiung CY, Huang EY, Ting HM, Huang HY,. Intensity-modulated radiotherapy for nasopharyngeal carcinoma: the reduction of radiation-induced trismus. Br J Radiol 2008; 81: 809-814.
48. Huang XM, Zheng YQ, Zhang XM, et al. Diagnosis and management of skull base osteoradionecrosis after radiotherapy for nasopharyngeal carcinoma. Laryngoscope 2006; 116: 1626-1631.